ETHYL 1-(4-METHOXYPHENYL)-3A-MORPHOLINO-7-OXO-6-(4-(2-OXOPIPERIDIN-1-YL)PHENYL)-3A,4,5,6,7,7A-HEXAHYDRO-1H-PYRAZOLO(3,4-C)PYRIDINE-3-CARBOXYLATE
UNII 3U5XMC2GP4
Substance Identification & Data
This profile provides standardized clinical and technical data for Ethyl 1-(4-methoxyphenyl)-3a-morpholino-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-3a,4,5,6,7,7a-hexahydro-1h-pyrazolo(3,4-c)pyridine-3-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3U5XMC2GP4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1619934-76-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H37N5O6 JQSLHGPCCDOOJM-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Ethyl 1-(4-methoxyphenyl)-3a-morpholino-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-3a,4,5,6,7,7a-hexahydro-1h-pyrazolo(3,4-c)pyridine-3-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.